Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 3, 2026	3	Initial filing by director officer or owner of more than ten percent	0002107264-26-000004.pdf 0002107264-26-000004.rtf 0002107264-26-000004.xls View HTML
February 3, 2026	4	Statement of changes in beneficial ownership of securities	0001591467-26-000001.pdf 0001591467-26-000001.rtf 0001591467-26-000001.xls View HTML
February 3, 2026	4	Statement of changes in beneficial ownership of securities	0002007730-26-000001.pdf 0002007730-26-000001.rtf 0002007730-26-000001.xls View HTML
February 3, 2026	4	Statement of changes in beneficial ownership of securities	0001762507-26-000001.pdf 0001762507-26-000001.rtf 0001762507-26-000001.xls View HTML
February 3, 2026	4	Statement of changes in beneficial ownership of securities	0001661887-26-000001.pdf 0001661887-26-000001.rtf 0001661887-26-000001.xls View HTML
February 3, 2026	4	Statement of changes in beneficial ownership of securities	0002107264-26-000005.pdf 0002107264-26-000005.rtf 0002107264-26-000005.xls View HTML
February 3, 2026	4	Statement of changes in beneficial ownership of securities	0001619834-26-000001.pdf 0001619834-26-000001.rtf 0001619834-26-000001.xls View HTML
February 2, 2026	144	Filed by "insiders" prior intended sale of restricted stock.	0001517022-26-000009.pdf 0001517022-26-000009.rtf View HTML
February 2, 2026	144	Filed by "insiders" prior intended sale of restricted stock.	0001517022-26-000010.pdf 0001517022-26-000010.rtf View HTML
February 2, 2026	144	Filed by "insiders" prior intended sale of restricted stock.	0001517022-26-000011.pdf 0001517022-26-000011.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax